Chief Executive Officer, Emmer Capital Partners Limited

Manishi Raychaudhuri

Chief Executive Officer

Emmer Capital Partners Limited

Emmer Capital Partners is an Asia Pacific focused financial advisory firm engaging in strategic financial asset allocation advice, bespoke thematic research and advising early-stage companies and connecting them to investors. Emmer Capital provides macro-economic and multi-asset investment strategy inputs to institutions, family offices, private wealth managers, private equity, and corporate boards directly and through independent research platforms. Emmer Capital also advises a wide range of startup companies on fund raising and business strategy. Emmer Capital's active engagement with the print and electronic media reaches a broad spectrum of investors across the globe.

Equity Bottom-Up

<ul>
<li>Basic materials, industrials, technology, consumer and distribution services, retail, healthcare drove China in 2025. China's policy focus and consumer preferences should drive some of them and few others in 2026.</li>
<li>Juxtaposing future earnings growth forecasts, forecast ROE and reasonable valuations, we identify six sectors: Communication Services, Basic Materials, Industrials, Consumer Durables, Retail Trade and Consumer Services in our focus list.</li>
<li>Eight stocks from these sectors are in our Asian Model Portfolio: Xiaomi, China Hongqiao, Zijin Mining, Alibaba, Lonking Holdings, Midea Group, Trip.com and Galaxy Entertainment.</li>
</ul>


Basic materials, industrials, technology, consumer and distribution services, retail, healthcare drove China in 2025. China's policy focus and consumer preferences should drive some of them and few others in 2026.
Juxtaposing future earnings growth forecasts, forecast ROE and reasonable valuations, we identify six sectors: Communication Services, Basic Materials, Industrials, Consumer Durables, Retail Trade and Consumer Services in our focus list.
Eight stocks from these sectors are in our Asian Model Portfolio: Xiaomi, China Hongqiao, Zijin Mining, Alibaba, Lonking Holdings, Midea Group, Trip.com and Galaxy Entertainment.


China up Close: What Worked in 2025 and What's Likely to Work Now

Asia Pac ECM and Index Rebal, Shenton Research

Ke Yan, CFA, FRM

Asia Pac ECM and Index Rebal

Asia Pac IPO & Placement Research, China Biotech

DZT Research

DZT Research is an independent Asia Pacific equity specialist. Our quantitative research covers index rebalancing flows, alongside exchange data analytics accross Asia Pacific. On the equity capital markets side, we focus on Asia Pacific ECM, especially biotech and TMT. Our lead analyst is frequently cited by international media.

Quantitative Analysis

<ul>
<li>We analysed the earning revision of component stocks of HS TECH in the past month.</li>
<li>We tabulated stocks with the top impact on index's EPS, stocks' EPS revision, and revenue revision.</li>
<li>We highlighted EPS revision on ALIBABA, JD.COM, LI AUTO, MEITUAN, XPENG.</li>
</ul>


We analysed the earning revision of component stocks of HS TECH in the past month.
We tabulated stocks with the top impact on index's EPS, stocks' EPS revision, and revenue revision.
We highlighted EPS revision on ALIBABA, JD.COM, LI AUTO, MEITUAN, XPENG.


HS TECH Index Earning Revision (Jan): ALIBABA, JD.COM, LI AUTO, MEITUAN, XPENG

<ul>
<li>We analyzed the latest HK SFC report for aggregate short position as of Jan 16th.</li>
<li>Top short increases and decreases were tabulated for one week and four week period.</li>
<li>We highlight short changes in Alibaba Health Information Technology, Xiaomi, Tencent, China Hongqiao, Gf Securities.</li>
</ul>


We analyzed the latest HK SFC report for aggregate short position as of Jan 16th.
Top short increases and decreases were tabulated for one week and four week period.
We highlight short changes in Alibaba Health Information Technology, Xiaomi, Tencent, China Hongqiao, Gf Securities.


HK Short Interest Weekly: Alibaba Health, Xiaomi, Tencent, China Hongqiao

Overseas Chinese Equities, Aequitas Research

Ming Lu

Overseas Chinese Equities

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

<ul>
<li>State Administration for Market Regulation (SAMR) launched an investigation into TCOM.</li>
<li>TCOM has a market share above 65% in the travel market.</li>
<li>We believe SAMR will not ruin TCOM - it just warns TCOM not to kill small companies.</li>
</ul>


State Administration for Market Regulation (SAMR) launched an investigation into TCOM.
TCOM has a market share above 65% in the travel market.
We believe SAMR will not ruin TCOM - it just warns TCOM not to kill small companies.


Trip.com (TCOM, 9961.HK): No Concern for Authorities Investigation

Asian Equities Analyst, Logistics & Transport, Tracking Traffic

Daniel Hellberg

Asian Equities Analyst, Logistics & Transport

Tracking Traffic

Focusing on Asian logistics, transportation, and travel companies

<ul>
<li>Chinese authorities have confirmed an investigation into Trip.com anticompetitive practices</li>
<li>The company could face fines of 1% - 10% of 2025 net revenue (up to US$800 mn)</li>
<li>A less likely outcome could be sweeping changes to the company's business model; AVOID</li>
</ul>


Chinese authorities have confirmed an investigation into Trip.com anticompetitive practices
The company could face fines of 1% - 10% of 2025 net revenue (up to US$800 mn)
A less likely outcome could be sweeping changes to the company's business model; AVOID


Trip.com Subject of Antitrust Investigation | Potentially Faces Large Fine or Forced Change to Model

Singapore

Trip.com Group is a leading global one-stop travel platform offering accommodation reservations, transportation ticketing, packaged tours, and corporate travel management services. It operates a portfolio of brands including Trip.com, Ctrip, Skyscanner, and Qunar. The company was founded in June 1999 and is headquartered in Shanghai, China.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Trip.com Group (9961 HK)

China up Close: What Worked in 2025 and What's Likely to Work Now

China's RatingDog Services PMI, 52.3 for Jan, surprised positively - in lie with our observation of services growth. Tech stocks are declining due...

Manishi Raychaudhuri

HS TECH Index Earning Revision (Jan): ALIBABA, JD.COM, LI AUTO, MEITUAN, XPENG

We analyzed HS TECH's consensus for Jan 2026 and highlighted changes of EPS in ALIBABA, JD.COM, LI AUTO, MEITUAN, XPENG.

Ke Yan, CFA, FRM

HK Short Interest Weekly: Alibaba Health, Xiaomi, Tencent, China Hongqiao

We analyzed the latest HK SFC report for aggregate short position as of Jan 16th and highlight short interest changes in Alibaba Health (241 HK),...

Ke Yan, CFA, FRM

Trip.com (TCOM, 9961.HK): No Concern for Authorities Investigation

SAMR launched an investigation into TCOM. TCOM has a market share above 65% in the travel market. We believe SAMR will not weaken TCOM, but just...

Ming Lu

Trip.com Subject of Antitrust Investigation | Potentially Faces Large Fine or Forced Change to Model

News of an antitrust investigation into Trip.com sent its shares plummeting last week. The company could face fines, changes to existing practices,...

Tracking Traffic

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)